Discontinued — last reported Q4 '25
Business Segments · Other Current Liabilities
RxTs Segment — Other Current Liabilities
McKesson RxTs Segment — Other Current Liabilities remained flat by 0.0% to $14.00M in Q1 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $14.00M to $14.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2025May 9, 2025
Rolls up toTotal Current Liabilities
How to read this metric
A significant increase may indicate rising operational costs or changes in payment terms, while a decrease suggests improved management of short-term liabilities.
Detailed definition
This captures short-term obligations within the RxTs segment that do not fall into standard categories like accounts pay...
Peer comparison
Standard component of working capital analysis across all distribution and service-based business segments.
Metric ID:
mck_segment_rxts_segment_other_current_liabilitiesHistorical Data
6 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|---|
| Value | $83.00M | $45.00M | $15.00M | $14.00M | $14.00M | $14.00M |
| QoQ Change | — | -45.8% | -66.7% | -6.7% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -83.1% | +0.0% |
Range$14.00M – $83.00M
CAGR-75.9%
Avg YoY Growth-41.6%
Median YoY Growth-41.6%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's rxts segment — other current liabilities?
- McKesson (MCK) reported rxts segment — other current liabilities of $14.00M in Q1 2025.
- How has McKesson's rxts segment — other current liabilities changed year-over-year?
- McKesson's rxts segment — other current liabilities decreased by 0.0% year-over-year, from $14.00M to $14.00M.
- What does rxts segment — other current liabilities mean?
- Miscellaneous short-term debts and obligations specific to the RxTs segment.